Yes: The use of Palivizumab in high risk infants reduces the risk of an RSV infection but does not prevent it in all cases. Infected infants with this med in their system generally have a very mild illness if they acquire the virus and rarely require hospitalization.
Answered 1/12/2015
5.9k views
A doctor has provided 1 answer
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question